A Self‐Adjuvanting Large Pore 2D Covalent Organic Framework as a Vaccine Platform
Angewandte Chemie International Edition · 27.01.2025 · 64 (5)
DOI: 10.1002/anie.202413020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 16.12.2024. Verfasst von Yalini H Wijesundara und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 West Campbell Rd, Richardson, 75080, TX, USA. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Vaccines, Metal-Organic Frameworks. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Welch Foundation.
Abstract (Originalsprache)
Vaccines are one of the greatest human achievements in public health, as they help prevent the spread of diseases, reduce illness and death rates, saving thousands of lives with few side effects. Traditional vaccine development is centered around using live attenuated or inactivated pathogens, which is expensive and has resulted in vaccine‐associated illnesses. Advancements have led to the development of safer subunit vaccines, which contain recombinant proteins isolated from pathogens. Their short half‐life and small size make most subunit vaccines less immunogenic. Here, we introduce a large pore 2D covalent organic framework (COF), PyCOFamide, as a promising solution for an effective subunit platform. Our study demonstrates that simple adsorption of a model antigen, ovalbumin (OVA), onto PyCOFamide (OVA@COF) significantly enhances humoral and cell‐mediated immune response compared to free OVA. OVA@COF exhibited heightened immune cell activation and acts as an antigen reservoir, facilitating antigen‐presenting cell trafficking to the draining lymph nodes, amplifying the humoral immune response. Additionally, the breakdown of the COF releases monomers that adjuvant the activation of immune cells vital to creating strong immunity. This platform offers a potential avenue for safer, more effective subunit vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 West Campbell Rd, Richardson, 75080, TX, USA.
- Department of Bioengineering, The University of Texas at Dallas, 800 West Campbell Rd, Richardson, 75080, TX, USA.
ORCID-Profile: Yalini H Wijesundara, Niyati Arora, Ryanne N Ehrman, Thomas Sinclair Howlett, Ikeda Trashi, Orikeda Trashi, Sneha Kumari, Wendy Tang, Katarzyna H Drewniak, Ziqi Wang, Ronald A Smaldone, Jeremiah J Gassensmith
Förderung
- Welch Foundation
Zitieren
APA
Wijesundara, Y. H., Arora, N., Ehrman, R. N., Howlett, T. S., Weyman, T. M., Trashi, I., Trashi, O., Kumari, S., Diwakara, S. D., Tang, W., Senarathna, M. C., Drewniak, K. H., Wang, Z., Smaldone, R. A., & Gassensmith, J. J. (2025). A Self‐Adjuvanting Large Pore 2D Covalent Organic Framework as a Vaccine Platform. Angewandte Chemie International Edition, 64(5). https://doi.org/10.1002/anie.202413020
Vancouver
Wijesundara YH, Arora N, Ehrman RN, Howlett TS, Weyman TM, Trashi I, et al. A Self‐Adjuvanting Large Pore 2D Covalent Organic Framework as a Vaccine Platform. Angewandte Chemie International Edition. 2025;64(5). doi:10.1002/anie.202413020
BibTeX
@article{Wijesundara2025,
author = {Wijesundara, Yalini H and Arora, Niyati and Ehrman, Ryanne N and Howlett, Thomas Sinclair and Weyman, Trevor M and Trashi, Ikeda and Trashi, Orikeda and Kumari, Sneha and Diwakara, Shashini D and Tang, Wendy and Senarathna, Milinda C and Drewniak, Katarzyna H and Wang, Ziqi and Smaldone, Ronald A and Gassensmith, Jeremiah J},
title = {A Self‐Adjuvanting Large Pore 2D Covalent Organic Framework as a Vaccine Platform},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {5},
doi = {10.1002/anie.202413020}
}
EUVIMED